{
    "medicine_id": "4a56d2ec2b2ba706f3c9a75c2064de2309b80153",
    "platform_id": "DB04936",
    "metadata": {
        "name": "Defitelio 80 mg 1mL Injection solution",
        "composition": "80 mg 1mL Tagatose",
        "clinical_particulars": {
            "therapeutic_indications": "Intended for use as a therapeutic adjunct in the treatment of type II diabetes",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Oral tagatose significantly blunts the rise in plasma glucose seen after oral glucose in patients with diabetes mellitus in a dose dependent manner without significantly affecting insulin levels The minimal elevation of plasma tagatose levels in normal patients and the adverse gastrointestinal effects seen following larger doses of tagatose support poor absorption of this hexose and suggest that tagatose may act by attenuating glucose absorption in the intestine",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09139",
                        "description": "Tagatose may decrease effectiveness of Technetium Tc 99m oxidronate as a diagnostic agent"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}